Cholestin Red Yeast Rice Shipments Halted Pending FDA Talks
This article was originally published in The Tan Sheet
Executive Summary
Pharmanex suspended U.S. shipments of Cholestin April 2 following a federal court decision affirming FDA's determination that the red yeast rice product is a drug, not a dietary supplement.